Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...

Low-dose ketamine for chronic refractory pain shows therapeutic benefit and high tolerability, according to a study.

New studies presented at ASTRO 2025 reveal low-dose radiation therapy significantly reduces arthritis pain and improves mobility in patients. Trials from South Korea and the US showed substantial pain ...

ZTlido ® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba ® is the subject of an exclusive, transferable license to use the ...

Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says. Ketamine infusions as part of comprehensive clinical pain care helped as many as 46% of patients ...

Scilex’s shareholders as of the record date of November 14, 2025 will receive one meme coin for each common share held. This digital collectible is intended to provide for immutable recognition of ...

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, ...

BRENTWOOD, Tenn., Oct. 28, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical, company that delivers life-changing medicines to patients with chronic, progressive diseases, ...

Currax Pharmaceuticals LLC ("Currax"), a pharmaceutical company that delivers life-changing medicines to patients with chronic, progressive diseases, today announced that leading obesity experts will ...